Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Probing depth ≥7 mm at baseline~2. Presence of ≥4 mm vertical bone defect with at least 1 bony wall after surgical debridement.~3. Adequate keratinized tissue to permit complete tissue coverage of defect.~4. Radiographic base of defect ≥3 mm coronal to the apex of the tooth.~Exclusion Criteria:~1. Failure to maintain adequate oral hygiene (plaque index\>2)~2. Pregnant and lactating women~3. History of oral cancer or HIV~4. Periodontal surgery on treatment-targeted tooth within the last year.~5. Tooth mobility greater than grade II.~6. Study tooth exhibiting a class III furacation defect~7. Localized aggressive periodontitis~8. Radiographic signs of untreated acute infection at the surgical site~9. Recent history of smoking more than 20 cigarettes/day~10. Known allergy to E.coli-derived products~11. Using an investigational therapy within the past 30 days.

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Drug Group (Type: EXPERIMENTAL): PERIOGEN
- Control group (Type: ACTIVE_COMPARATOR): Beta TCP alone

Based on this trial design, predict the completion outcome and termination type (if applicable).